Nurix Therapeutics (NRIX) Leases (2021 - 2025)
Historic Leases for Nurix Therapeutics (NRIX) over the last 5 years, with Q4 2025 value amounting to $50.5 million.
- Nurix Therapeutics' Leases rose 7952.66% to $50.5 million in Q4 2025 from the same period last year, while for Nov 2025 it was $50.5 million, marking a year-over-year increase of 7952.66%. This contributed to the annual value of $50.5 million for FY2025, which is 7952.66% up from last year.
- Nurix Therapeutics' Leases amounted to $50.5 million in Q4 2025, which was up 7952.66% from $53.0 million recorded in Q3 2025.
- Nurix Therapeutics' Leases' 5-year high stood at $53.0 million during Q3 2025, with a 5-year trough of $5.8 million in Q2 2025.
- In the last 5 years, Nurix Therapeutics' Leases had a median value of $15.9 million in 2022 and averaged $22.4 million.
- As far as peak fluctuations go, Nurix Therapeutics' Leases skyrocketed by 20002.22% in 2024, and later tumbled by 7988.56% in 2025.
- Quarter analysis of 5 years shows Nurix Therapeutics' Leases stood at $14.0 million in 2021, then dropped by 11.85% to $12.3 million in 2022, then surged by 152.26% to $31.1 million in 2023, then decreased by 9.64% to $28.1 million in 2024, then surged by 79.53% to $50.5 million in 2025.
- Its Leases stands at $50.5 million for Q4 2025, versus $53.0 million for Q3 2025 and $5.8 million for Q2 2025.